To weigh the practical effects of TCF11, Nrf1α and Nrf2 on human hepatocellular carcinoma (HCC), their relevancies to the overall survival (OS) of HCC patients were firstly investigated (Figure 8). Here, NFE2L2 is linked to hepatocellular carcinoma.